DONEPEZIL DERIVATIVES AS DUAL ACETYLCHOLINESTERASE AND b-SECRETASE 1 INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE

Introduction: This work is focused on the study of the inhibition activity exerted by some donepezil derivatives, on the acetlycholinesterase and b-secretase 1 (Bace-1) activities, potentially useful as dual inhibitors for the treatment of Alzheimer’s disease (AD). Results: The Authors report the effect produced by some donepezil derivatives on the enzymatic activity of acetlycholinesterase and Bace-1. Conclusion: In vitro AChE activity inhibition represent an useful approach to identity molecular candidates for a more appropriate AD therapy.